InvestorsHub Logo
Followers 3
Posts 159
Boards Moderated 0
Alias Born 06/06/2011

Re: sts66 post# 53724

Tuesday, 07/14/2015 5:41:55 PM

Tuesday, July 14, 2015 5:41:55 PM

Post# of 429261
Sts; Amarin filed suit in federal court against the FDA for the right to use truthful and non misleading speech in promotion of Vasepa. Freedom of speech as allowed by the 1st Amendment of the Constitution is prohibited by the FDA with respect to off label speech. In addition to this,they are seeking a preliminary injunction to allow them to engage in this "prohibited" speech for the off label promotion of Vasepa which is prohibited as well by the FDA until this case is adjudicated.

Sorry if this appears overly simplified but this kind of simplicity helps me understand things abstract to my way of thinking.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News